Founded more than 40 years ago, Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, governmental and academic laboratories.

- Led the successful commercial and operational integration of Advion Inc. (Ithaca, NY) and Interchim SA (Montlucon, France), enhancing company's capabilities in providing separation, purification, and identification solutions for chemists and biochemists worldwide.- Achieved a significant 27% increase in consolidated revenue over two years (2021-2022) through strategic planning, optimizing synergies, and expanding into rapidly growing markets.- Recorded the highest revenue in Advion's history in 2022.- Improved gross margins by 450 basis points during 2020-2022 through the implementation of various Kaizen initiatives.- Implemented a new ERP system, streamlining business processes and boosting operational efficiency.- Successfully established a new subsidiary in Japan (AIS KK) and a joint venture in India, leveraging a strong business network and assembling experienced teams to achieve profitability in the second year.- Launched Advion's innovative "Solation ICP-MS" platform, expanding company's product offerings.

- Co-founded Sigma Analytical Services, a GMP-accredited laboratory specializing in pharmaceutical and cannabis testing services in Canada.- Directed all aspects of the business, including fund-raising, sales, marketing, operations, quality control, R&D, and regulatory compliance.- Provided a wide range of analysis services, including elemental, molecular, pesticide, genetic, and pathogen testing, complemented by expert consulting for new product development.- Grew the company from its inception in 2018 to achieving profitability by 2020.

- Managed the mass spectrometry product line, encompassing instruments, services, and consumables.- Oversaw all aspects of the business, including sales, marketing, R&D, product management, new application development, operations, customer service, quality, finance, and regulatory compliance.- Achieved over 50% annual growth for two consecutive years in the LC-MS/MS segment by targeting high-growth applications and markets.- Led PerkinElmer’s cannabis testing initiatives across multiple units, delivering comprehensive solutions that met diverse customer needs.- Directed the due diligence, acquisition, and successful integration of Ionics MS Group and Torion, launching new mass spectrometry and chromatography platforms within two years of acquisition.- Refined company's mass spectrometry strategy by reorganizing R&D teams and renegotiating OEM contracts for enhanced efficiency.- Executed initiatives to enhance gross margins, including the phasing out of low-margin product lines.- Successfully obtained the ISO 13485 quality standard certification for the manufacturing site.

- Reorganized and managed a global team of Research scientists and engineers across company's product lines, including ICP, ICP-MS, AA, IR, UV, GC, LC, and MS.- Established technology teams focused on key platforms and implemented a new technology development process centered on customer feedback.- Launched and delivered multiple new product introductions, outperforming the market in terms of growth.- Established strategic relationships with leading academic and industrial research organizations

- Managed a team of scientists and engineers responsible for designing and developing the elemental mass spectrometry product line (ICP-MS) from ideation to launch.- Led the transition of PerkinElmer-SCIEX ICP-MS JV team (R&D and Manufacturing) from SCIEX to PerkinElmer after the acquisition of the JV in May 2010, by establishing an R&D center in Toronto and moving the manufacturing line from Toronto to Shelton, CT